Status:
COMPLETED
A Comparison of Classic and Virtual Inhaler Training Methods in COPD Patients
Lead Sponsor:
Ayse Baha
Conditions:
COPD
Inhaler Training
Eligibility:
All Genders
40-65 years
Phase:
NA
Brief Summary
According to the World Health Organization data, the third most common cause of death in the world, is COPD , a disease that progresses with exacerbations (1). Exacerbations are the most important cau...
Detailed Description
Our aim is to investigate whether video-mediated virtual inhaler training is successful in patients with COPD METHOD OF WORKING Patients hospitalized due to COPD exacerbation and are ready to be dis...
Eligibility Criteria
Inclusion
- Patients who have not used MDI for at least 1 year.
- Having COPD diagnosed with PFT (FEV1/FVC \<70 in PFT in the last 1 year)
- Being hospitalized with a COPD exacerbation and being discharged
- Not having a hearing loss, mental disability, visual impairment and a physical impairment that would prevent the use of MDI
- To have the necessary technological equipment to establish video communication on the phone
- Who have agreed to participate in the study.
Exclusion
- Patients who have used MDI or have training MDI for at least 1 year.
- Having a hearing loss, mental disability, visual impairment and a physical impairment that would prevent the use of MDI
- Have not the necessary technological equipment to establish video communication on the phone
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT05335265
Start Date
October 1 2021
End Date
December 31 2021
Last Update
April 28 2022
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara City Hospital
Ankara, Turkey (Türkiye)
2
Gazi University Faculty of Medicine
Ankara, Turkey (Türkiye)
3
Ufuk University Faculty of Medicine
Ankara, Turkey (Türkiye)
4
Muratpasa District Health Directorate
Antalya, Turkey (Türkiye)